Alto Neuroscience (ANRO) Depreciation and Depletion (2024 - 2026)
Alto Neuroscience's (ANRO) quarterly Depreciation and Depletion came in at $184000.0 in Q1 2026, up 7.6% year-on-year from $171000.0 in Q1 2025, and down 6.12% quarter-over-quarter from $196000.0 in Q4 2025.
Alto Neuroscience (ANRO) Depreciation and Depletion (2024 - 2026) Analysis & Trends
Alto Neuroscience has disclosed Depreciation and Depletion across 3 years of filings, most recently posting $184000.0 for Q1 2026.
- Depreciation and Depletion for Q1 2026 came in at $184000.0, up 7.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $751000.0 (changed N/A YoY), and the FY2025 annual result was $700000.0, up 40.0% from the prior year.
- Depreciation and Depletion came in at $184000.0 for Q1 2026 at Alto Neuroscience, down from $196000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $200000.0 in Q3 2024 to a low of $168000.0 in Q4 2024.
- The 3-year median for Depreciation and Depletion is $190000.0 (2025), against an average of $186500.0.
- Peak annual rise in Depreciation and Depletion reached 16.67% in 2025, while the deepest fall reached 0.0% in 2025.
- Alto Neuroscience's Depreciation and Depletion stood at $168000.0 in 2024, then grew by 16.67% to $196000.0 in 2025, then retreated by 6.12% to $184000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $184000.0 (Q1 2026), $196000.0 (Q4 2025), and $200000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Alto Neuroscience | 643.06 Mn | 379.30 Mn | - | 184,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 184,000.00 |
| Mar 31, 2026 | 184,000.00 |
| Dec 31, 2025 | 196,000.00 |
| Dec 31, 2025 | 196,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 171,000.00 |
| Mar 31, 2025 | 171,000.00 |
| Dec 31, 2024 | 168,000.00 |
| Dec 31, 2024 | 168,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |